Ewing's sarcoma of the femur: Prognosis in 69 patients treated by the CESS group |
| |
Authors: | Toshifumi Ozaki Axel Hillmann Christiane Hoffmann Christian Rü be Barbara Dockhorn-Dworniczak Sebastian Blasius Jü rgen Dunst J rn Treuner Herbert Jü rgens Winfried Winkelmann |
| |
Institution: | Toshifumi Ozaki ,Axel Hillmann,Christiane Hoffmann,Christian Rü,be,Barbara Dockhorn-Dworniczak,Sebastian Blasius,Jü,rgen Dunst,Jö,rn Treuner,Herbert Jü,rgens,Winfried Winkelmann |
| |
Abstract: | We reviewed the treatment outcome of 69 patients with Ewing's sarcoma of the femur. The patients received chemotherapy according to the CESS 81 (n 14), CESS 86 (n 43), and CESS 91P (n 12) protocols. The 10-year relapse-free survival rates were 36%, 65%, and 65% (p = 0.01). 68 patients received local treatment. The primary tumor was treated by surgery without radiotherapy in 28 patients; 1 developed a local recurrence and 7 metastases. 10 patients received radiotherapy alone; 4 developed metastases and 4 local recurrences and metastases. 30 cases had a combination of surgery and radiotherapy; 7 developed metastases and 1 a local recurrence and metastasis. The survival of patients after radiotherapy alone was worse than that of patients after surgery with/without radiotherapy (p = 0.005). Pathological fractures (n 16) did not influence the prognosis. |
| |
Keywords: | |
本文献已被 InformaWorld 等数据库收录! |
|